Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (51-60 of 409) with videos related to

Pageof 41
Sort By:
The Lancet. Neurology|September 22, 2007
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directionsBrenda Banwell, Angelo Ghezzi, Amit Bar-Or, et al.
Frontiers in Immunology|January 22, 2016
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS AutoimmunityNatalia B Pikor, Alexandre Prat, Amit Bar-Or, et al.
Journal of Immunological Methods|August 25, 2012
A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samplesChahrazed Belabani, Sathyanath Rajasekharan, Viviane Poupon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 18, 2025
Exploring the Clinical Utility of Neurofilament Light Chain Assays in Multiple Sclerosis ManagementAmit Bar-Or, Jacqueline Nicholas, Jenny Feng, et al.
Nature Medicine|May 10, 2022
Guilty by association: Epstein-Barr virus in multiple sclerosisAmit Bar-Or, Brenda Banwell, Joseph R Berger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Patient and community preferences for treatments and health states in multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Neuroimmunology and Neuroinflammation|July 31, 2025
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosisLeah R Zuroff, Joyce A Benjamins, Amit Bar-Or, et al.
Nature Reviews. Neurology|January 13, 2011
Therapies for multiple sclerosis: considerations in the pediatric patientBrenda Banwell, Amit Bar-Or, Gavin Giovannoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 3, 2002
The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Pageof 41

Showing results (51-60 of 409) with videos related to

Sort By:
Pageof 41
The Lancet. Neurology|September 22, 2007
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directionsBrenda Banwell, Angelo Ghezzi, Amit Bar-Or, et al.
Frontiers in Immunology|January 22, 2016
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS AutoimmunityNatalia B Pikor, Alexandre Prat, Amit Bar-Or, et al.
Journal of Immunological Methods|August 25, 2012
A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samplesChahrazed Belabani, Sathyanath Rajasekharan, Viviane Poupon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 18, 2025
Exploring the Clinical Utility of Neurofilament Light Chain Assays in Multiple Sclerosis ManagementAmit Bar-Or, Jacqueline Nicholas, Jenny Feng, et al.
Nature Medicine|May 10, 2022
Guilty by association: Epstein-Barr virus in multiple sclerosisAmit Bar-Or, Brenda Banwell, Joseph R Berger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Patient and community preferences for treatments and health states in multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Neuroimmunology and Neuroinflammation|July 31, 2025
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosisLeah R Zuroff, Joyce A Benjamins, Amit Bar-Or, et al.
Nature Reviews. Neurology|January 13, 2011
Therapies for multiple sclerosis: considerations in the pediatric patientBrenda Banwell, Amit Bar-Or, Gavin Giovannoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 3, 2002
The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Pageof 41